Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2024-01-30 00:00:00 ET · period of report 2024-01-29 · accession 0000950170-24-009005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-30 | 2024-01-29 | APVO | Taylor Daphne | SVP, CFO | M - OptEx | — | +792 | 13.2K | +6% | — |
| D | 2024-01-30 | 2024-01-29 | APVO | Taylor Daphne | SVP, CFO | M - OptEx | $0.00 | -792 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-29 | M | A | 792 | — | 13,160 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2024-01-29 | M | D | 792 | $0.00 | 0 | D | — · — to — | 792 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On January 29, 2021, the reporting person was granted 2,375 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022. |